Daily Roundup

8CO.ASX BIO.ASX PPL.ASX AFL.ASX AVA.ASX

Strong Q3 Drives Record Revenue for 8COMMON

8COMMON Ltd (ASX: 8CO) has reported a standout quarter, with record transaction and recurring SaaS revenue of $1.1 million, up 5% on the prior corresponding period. The fintech company also saw cash receipts from operations reach $1.7 million, while maintaining tight cost controls that resulted in a net operating cash outflow of just $54,000.

8COMMON's Annualised Recurring Revenue (ARR) now stands at around $5 million, with ARPU increasing 10% year-over-year to $26.76. The company has made key infrastructure and technology upgrades, onboarded new customers, and completed the transition of the Federal Government's Travel and Procurement Payment Services to NAB payment cards.

Looking ahead, 8COMMON expects a temporary slowdown in business development activities due to the upcoming Federal Election, but anticipates a pickup in activity post-election in mid-May. The company's reseller partnerships continue to strengthen, and it expects meaningful results from these channels.

Biome Launches New Probiotic Products for Women's Health

Biome Australia (ASX: BIO) is expanding its Activated Probiotics range with two new targeted products for women's health. The first is Biome Her™ Pessary, a vaginally-inserted probiotic containing clinically-trialled strains to help reduce recurrence of vaginal thrush. The second is Biome Perinatal™ Probiotic, formulated with strains that have demonstrated benefits for healthy pregnancy, maternal health, and postpartum mood.

With women's health supplements being a top-selling category in Australia, and prenatal vitamin sales reaching $98.6 million in 2024, Biome sees significant opportunities to support women through key life stages with its new evidence-based probiotic solutions. The company is focused on providing innovative natural medicines to healthcare practitioners and consumers.

Pureprofile Delivers Strong Q3 with 16% Revenue Growth

Pureprofile Ltd (ASX: PPL) has reported a standout Q3 FY25, with record quarterly revenue of $12.7 million, up 16% on the prior corresponding period. Year-to-date revenue reached $41.9 million, a 20% increase, driven by growth across key regions.

The Rest of World (ROW) segment, including the UK, US, and South East Asia, saw a 24% uplift in revenue, highlighting Pureprofile's successful global expansion. The ANZ region also grew 10%, reflecting the contribution of the i-link acquisition and the team's strong performance.

Pureprofile's EBITDA grew 16% to $0.6 million, in line with seasonal expectations. The company continues to focus on driving growth, expanding client relationships, and improving margins through automation and AI-powered solutions.

AF Legal Delivers Fourth Consecutive Profitable Quarter

AF Legal Group Ltd (ASX: AFL) has reported a strong Q3 FY25, with revenue of $7.0 million, up 9% on the prior quarter and 43% on the prior year. This was driven in part by the inclusion of the Armstrong Legal acquisitions.

Notably, the company recorded its fourth consecutive quarter of profitability, with normalised net profit before tax attributable to owners reaching $352,000. Year-to-date, AF Legal's revenue already reflects 91% of the total FY24 revenue and 117% of the total FY24 normalised NPBT.

The company's balance sheet remains robust, and its Project Titan technology upgrade is on track and under budget. AF Legal expects Q4 to further consolidate its steady profitable growth, driven by its focus on people management, digital platform enhancements, and the expansion of the Armstrong Legal teams.

Ava Risk Group Sees Strong Sales Pipeline for Q4

Ava Risk Group Limited (ASX: AVA) has provided a Q3 FY2025 trading update, reporting solid sales order intake of $6.5 million. This brings the company's year-to-date sales order intake to $22.8 million.

While Q3 sales were slightly softer than expected due to geopolitical instability, Ava Risk Group has a strong sales opportunity pipeline that is expected to drive acceleration in Q4 sales order intake. The company's order backlog at the end of Q3 stood at $7.4 million, including $2.5 million in annual recurring revenue.

Ava Risk Group is confident in delivering solid growth in revenue and EBITDA for FY2025, with the telecommunications sector expected to provide significant opportunities both in Australia and internationally.